Literature DB >> 1958636

Rodent models of congenital and hereditary cataract in man.

B J Tripathi1, R C Tripathi, N S Borisuth, R Dhaliwal, D Dhaliwal.   

Abstract

Because the organogenesis and physiology of the lens are essentially similar in various mammals, an understanding of the etiology and pathogenesis of the formation of cataract in an animal model will enhance our knowledge of cataractogenesis in man. In this review, we summarize the background, etiology, and pathogenesis of cataracts that occur in rodents. The main advantages of using rodent mutants include the well-researched genetics of the animals and the comparative ease of breeding of large litters. Numerous rodent models of congenital and hereditary cataracts have been studied extensively. In mice, the models include the Cts strain, Fraser mouse, lens opacity gene (Lop) strain, Lop-2 and Lop-3 strains, Philly mouse, Nakano mouse, Nop strain, Deer mouse, Emory mouse, Swiss Webster strain, Balb/c-nct/nct mouse, and SAM-R/3 strain. The rat models include BUdR, ICR, Sprague-Dawley, and Wistar rats, the spontaneously hypertensive rat (SHR), the John Rapp inbred strain of Dahl salt-sensitive rat, as well as WBN/Kob, Royal College of Surgeons (RCS), and Brown-Norway rats. Other proposed models for the study of hereditary cataract include the degu and the guinea pig. Because of the ease of making clinical observations in vivo and the subsequent availability of the intact lens for laboratory analyses at different stages of cataract formation, these animals provide excellent models for clinicopathologic correlations, for monitoring of the natural history of the aging process and of metabolic defects, as well as for investigations on the effect of cataract-modulating agents and drugs, including the prospect of gene therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1958636

Source DB:  PubMed          Journal:  Lens Eye Toxic Res        ISSN: 1042-6922


  7 in total

1.  Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat.

Authors:  Masayuki Mori; Guixin Li; Ikuro Abe; Jun Nakayama; Zhanjun Guo; Jinko Sawashita; Tohru Ugawa; Shoko Nishizono; Tadao Serikawa; Keiichi Higuchi; Seigo Shumiya
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

2.  Alterations in lenticular proteins during ageing and selenite-induced cataractogenesis in Wistar rats.

Authors:  Muniyan Sakthivel; Rajan Elanchezhian; Philip A Thomas; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2010-03-16       Impact factor: 2.367

3.  The locus for an inherited cataract in sheep maps to ovine chromosome 6.

Authors:  Gareth R S Wilson; James D Morton; David N Palmer; John C McEwan; Karl Gately; Rayna M Anderson; Ken G Dodds
Journal:  Mol Vis       Date:  2012-05-31       Impact factor: 2.367

4.  Looking the cow in the eye: deletion in the NID1 gene is associated with recessive inherited cataract in Romagnola cattle.

Authors:  Leonardo Murgiano; Vidhya Jagannathan; Valerio Calderoni; Monika Joechler; Arcangelo Gentile; Cord Drögemüller
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

5.  Age-related changes in eye lens biomechanics, morphology, refractive index and transparency.

Authors:  Catherine Cheng; Justin Parreno; Roberta B Nowak; Sondip K Biswas; Kehao Wang; Masato Hoshino; Kentaro Uesugi; Naoto Yagi; Juliet A Moncaster; Woo-Kuen Lo; Barbara Pierscionek; Velia M Fowler
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

6.  Human multidrug resistance 3-P-glycoprotein expression in transgenic mice induces lens membrane alterations leading to cataract.

Authors:  I Dunia; J J Smit; M A van der Valk; H Bloemendal; P Borst; E L Benedetti
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

7.  Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats.

Authors:  Ryoka Goto; Shigehiro Yamada; Hiroko Otake; Yosuke Nakazawa; Mikako Oka; Naoki Yamamoto; Hiroshi Sasaki; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.